Status:
TERMINATED
Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer
Lead Sponsor:
Institut Bergonié
Conditions:
Breast Cancer
Eligibility:
FEMALE
50-100 years
Phase:
PHASE3
Brief Summary
This randomized phase III trial is studying surgery and axillary lymph node dissection to evaluate if systematic Axillary Lymph Node Excision can be avoided in locoregional treatment for operable brea...
Detailed Description
Phase III randomized multicenter equivalence trial evaluating the role of Axillary Lymph Node Excision. Primary aim is to assess if it is possible to avoid routine Axillary Lymph Node Excision during...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Women, 50 year or more Menopausal women Breast cancer Macroscopic tumor size of 10 mm or less (measured during operation) No palpable axillary node ( N0)
- Exclusion criteria:
- Previous cancer history life expectancy \< 10 years Metastasis
Exclusion
Key Trial Info
Start Date :
September 1 1995
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
625 Patients enrolled
Trial Details
Trial ID
NCT00210236
Start Date
September 1 1995
End Date
December 1 2005
Last Update
October 17 2025
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire d'Agen
Agen, France, 47000
2
Centre Régional de Lutte Contre le Cancer d'Anger
Angers, France, 49000
3
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest
Bordeaux, France, 33076
4
Centre Régional de Luttre Contre le Cancer de Clermont Ferrand
Clermont-Ferrand, France, 63000